GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Boston Scientific Corp (BSP:B1SX34) » Definitions » Cyclically Adjusted PS Ratio

Boston Scientific (BSP:B1SX34) Cyclically Adjusted PS Ratio : 8.74 (As of May. 15, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Boston Scientific Cyclically Adjusted PS Ratio?

As of today (2024-05-15), Boston Scientific's current share price is R$376.96. Boston Scientific's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was R$43.11. Boston Scientific's Cyclically Adjusted PS Ratio for today is 8.74.

The historical rank and industry rank for Boston Scientific's Cyclically Adjusted PS Ratio or its related term are showing as below:

BSP:B1SX34' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.44   Med: 5.28   Max: 8.64
Current: 8.61

During the past years, Boston Scientific's highest Cyclically Adjusted PS Ratio was 8.64. The lowest was 1.44. And the median was 5.28.

BSP:B1SX34's Cyclically Adjusted PS Ratio is ranked worse than
82.7% of 474 companies
in the Medical Devices & Instruments industry
Industry Median: 2.165 vs BSP:B1SX34: 8.61

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Boston Scientific's adjusted revenue per share data for the three months ended in Mar. 2024 was R$12.960. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is R$43.11 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Boston Scientific Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Boston Scientific's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Boston Scientific Cyclically Adjusted PS Ratio Chart

Boston Scientific Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.12 5.51 5.89 5.86 6.85

Boston Scientific Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.18 6.55 6.29 6.85 8.03

Competitive Comparison of Boston Scientific's Cyclically Adjusted PS Ratio

For the Medical Devices subindustry, Boston Scientific's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Boston Scientific's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Boston Scientific's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Boston Scientific's Cyclically Adjusted PS Ratio falls into.



Boston Scientific Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Boston Scientific's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=376.96/43.11
=8.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Boston Scientific's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Boston Scientific's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=12.96/129.4194*129.4194
=12.960

Current CPI (Mar. 2024) = 129.4194.

Boston Scientific Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 3.114 100.560 4.008
201409 3.203 100.428 4.128
201412 3.758 99.070 4.909
201503 4.164 99.621 5.410
201506 4.211 100.684 5.413
201509 5.483 100.392 7.068
201512 5.704 99.792 7.397
201603 5.302 100.470 6.830
201606 5.362 101.688 6.824
201609 4.963 101.861 6.306
201612 5.309 101.863 6.745
201703 4.859 102.862 6.114
201706 5.347 103.349 6.696
201709 4.993 104.136 6.205
201712 5.686 104.011 7.075
201803 5.585 105.290 6.865
201806 6.712 106.317 8.171
201809 7.003 106.507 8.510
201812 7.073 105.998 8.636
201903 6.798 107.251 8.203
201906 7.202 108.070 8.625
201909 7.897 108.329 9.434
201912 8.434 108.420 10.068
202003 8.791 108.902 10.447
202006 7.366 108.767 8.765
202009 10.035 109.815 11.826
202012 9.761 109.897 11.495
202103 10.839 111.754 12.552
202106 10.801 114.631 12.194
202109 10.782 115.734 12.057
202112 12.312 117.630 13.546
202203 10.469 121.301 11.170
202206 11.389 125.017 11.790
202209 11.543 125.227 11.929
202212 11.787 125.222 12.182
202303 12.207 127.348 12.406
202306 11.996 128.729 12.060
202309 11.809 129.860 11.769
202312 12.360 129.419 12.360
202403 12.960 129.419 12.960

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Boston Scientific  (BSP:B1SX34) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Boston Scientific Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Boston Scientific's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Boston Scientific (BSP:B1SX34) Business Description

Address
300 Boston Scientific Way, Marlborough, MA, USA, 01752-1234
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

Boston Scientific (BSP:B1SX34) Headlines

No Headlines